Amber D. Steele

Array ( [id] => 6645084 [patent_doc_number] => 20100227901 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-09 [patent_title] => 'COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/279808 [patent_app_country] => US [patent_app_date] => 2007-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13660 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20100227901.pdf [firstpage_image] =>[orig_patent_app_number] => 12279808 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5291054 [patent_doc_number] => 20090023784 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-22 [patent_title] => 'USE OF DEFERIPRONE AND METHODS TO TREAT AND/OR PREVENT FRIEDREICH ATAXIA RESULTING FROM INTRACELLULAR MISHANDLING OF IRON' [patent_app_type] => utility [patent_app_number] => 12/279930 [patent_app_country] => US [patent_app_date] => 2007-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11367 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20090023784.pdf [firstpage_image] =>[orig_patent_app_number] => 12279930 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5416970 [patent_doc_number] => 20090042857 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-12 [patent_title] => 'Novel Pharmaceutical' [patent_app_type] => utility [patent_app_number] => 12/224130 [patent_app_country] => US [patent_app_date] => 2007-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33829 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20090042857.pdf [firstpage_image] =>[orig_patent_app_number] => 12224130 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5522089 [patent_doc_number] => 20090030070 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-29 [patent_title] => 'EXTERNAL PREPARATION FOR SKIN CONTAINING FLAVANONE DERIVATIVE' [patent_app_type] => utility [patent_app_number] => 12/162961 [patent_app_country] => US [patent_app_date] => 2007-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12741 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0030/20090030070.pdf [firstpage_image] =>[orig_patent_app_number] => 12162961 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5290982 [patent_doc_number] => 20090023712 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-22 [patent_title] => 'Pharmaceutical Compositions for the Treatment of Attention Deficit Hyperactivity Disorder Comprising Flibanserin' [patent_app_type] => utility [patent_app_number] => 12/279589 [patent_app_country] => US [patent_app_date] => 2007-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8723 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20090023712.pdf [firstpage_image] =>[orig_patent_app_number] => 12279589 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5361745 [patent_doc_number] => 20090036539 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-05 [patent_title] => 'STABLE HYPERBARIC COMPOSITION COMPRISING PRILOCAINE HCL, USE OF SAID NEW COMPOSITION FOR INTRATHECAL ANAETHESIA, AND METHOD FOR MANUFACTURING SAID COMPOSITION' [patent_app_type] => utility [patent_app_number] => 12/279049 [patent_app_country] => US [patent_app_date] => 2007-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3193 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20090036539.pdf [firstpage_image] =>[orig_patent_app_number] => 12279049 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5259719 [patent_doc_number] => 20070213351 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-13 [patent_title] => 'Spirocyclic cyclohexane compounds' [patent_app_type] => utility [patent_app_number] => 11/705096 [patent_app_country] => US [patent_app_date] => 2007-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14452 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20070213351.pdf [firstpage_image] =>[orig_patent_app_number] => 11705096 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5131636 [patent_doc_number] => 20070208033 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-06 [patent_title] => 'Amine compound and use thereof' [patent_app_type] => utility [patent_app_number] => 11/704860 [patent_app_country] => US [patent_app_date] => 2007-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 94506 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20070208033.pdf [firstpage_image] =>[orig_patent_app_number] => 11704860 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5063704 [patent_doc_number] => 20070225344 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-27 [patent_title] => 'Sulfonamide derivatives to treat infection with hepatitis C virus' [patent_app_type] => utility [patent_app_number] => 11/703631 [patent_app_country] => US [patent_app_date] => 2007-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7284 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0225/20070225344.pdf [firstpage_image] =>[orig_patent_app_number] => 11703631 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5436315 [patent_doc_number] => 20090170902 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'COMPOUNDS WHICH POTENTIATE GLUTAMATE RECEPTOR AND USES THEREOF IN MEDICINE' [patent_app_type] => utility [patent_app_number] => 12/278604 [patent_app_country] => US [patent_app_date] => 2007-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12351 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20090170902.pdf [firstpage_image] =>[orig_patent_app_number] => 12278604 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4955529 [patent_doc_number] => 20080188553 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-07 [patent_title] => 'NOVEL ASCORBIC ACID COMPOUNDS, METHODS OF SYNTHESIS AND APPLICATION USE THEREOF' [patent_app_type] => utility [patent_app_number] => 11/671920 [patent_app_country] => US [patent_app_date] => 2007-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6993 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0188/20080188553.pdf [firstpage_image] =>[orig_patent_app_number] => 11671920 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5310881 [patent_doc_number] => 20090018162 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-15 [patent_title] => 'USE OF 6-(3-CHLORO-2-FLUOROBENZYL)-1-[(2S)-1-HYDROXY-3-METHYLBUTAN-2-YL]-7-METHOXY-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID OR SALT THEREOF FOR TREATING RETROVIRUS INFECTION' [patent_app_type] => utility [patent_app_number] => 12/162975 [patent_app_country] => US [patent_app_date] => 2007-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15523 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20090018162.pdf [firstpage_image] =>[orig_patent_app_number] => 12162975 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10540618 [patent_doc_number] => 09265721 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-02-23 [patent_title] => 'Composition for promoting vascular smooth muscle relaxation' [patent_app_type] => utility [patent_app_number] => 12/223583 [patent_app_country] => US [patent_app_date] => 2007-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 4821 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 139 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12223583 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6177926 [patent_doc_number] => 20110178112 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-21 [patent_title] => 'PPAR Modulators' [patent_app_type] => utility [patent_app_number] => 12/161317 [patent_app_country] => US [patent_app_date] => 2007-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 23993 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0178/20110178112.pdf [firstpage_image] =>[orig_patent_app_number] => 12161317 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5473008 [patent_doc_number] => 20090246174 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-01 [patent_title] => 'TREATMENT FOR CUTANEOUS T CELL LYMPHOMA' [patent_app_type] => utility [patent_app_number] => 12/159058 [patent_app_country] => US [patent_app_date] => 2006-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6415 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0246/20090246174.pdf [firstpage_image] =>[orig_patent_app_number] => 12159058 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5046664 [patent_doc_number] => 20070265338 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-15 [patent_title] => 'USE OF L-CARNITINE OR OF ALKANOYL L-CARNITINES FOR THE PREPARATION OF A PHYSIOLOGICAL SUPPLEMENT OR MEDICAMENT FOR OPHTHALMIC USE IN THE FORM OF EYE DROPS' [patent_app_type] => utility [patent_app_number] => 11/570662 [patent_app_country] => US [patent_app_date] => 2006-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6540 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0265/20070265338.pdf [firstpage_image] =>[orig_patent_app_number] => 11570662 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6590182 [patent_doc_number] => 20100130460 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'TOPICAL GLUCOCORTICOSTEROID FORMULATIONS' [patent_app_type] => utility [patent_app_number] => 12/096753 [patent_app_country] => US [patent_app_date] => 2006-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5936 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20100130460.pdf [firstpage_image] =>[orig_patent_app_number] => 12096753 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6498945 [patent_doc_number] => 20100286191 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => '2-Arylthiazole Derivatives as CXCR3 Receptor Modulators' [patent_app_type] => utility [patent_app_number] => 12/086361 [patent_app_country] => US [patent_app_date] => 2006-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38249 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20100286191.pdf [firstpage_image] =>[orig_patent_app_number] => 12086361 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4853336 [patent_doc_number] => 20080319079 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-25 [patent_title] => 'Method for Administering Formoterol Using a Nebulizer' [patent_app_type] => utility [patent_app_number] => 12/094947 [patent_app_country] => US [patent_app_date] => 2006-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4694 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0319/20080319079.pdf [firstpage_image] =>[orig_patent_app_number] => 12094947 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6355789 [patent_doc_number] => 20100022510 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-28 [patent_title] => 'Crystalline Forms' [patent_app_type] => utility [patent_app_number] => 12/093954 [patent_app_country] => US [patent_app_date] => 2006-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6508 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20100022510.pdf [firstpage_image] =>[orig_patent_app_number] => 12093954 [rel_patent_id] =>[rel_patent_doc_number] =>)